Protagonist Therapeutics Inc (PTGX) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States.

Total Assets Chart for Protagonist Therapeutics Inc

Protagonist Therapeutics Inc (PTGX) total assets for FY2025 were USD 669.9M, a -10.0% change from FY2024. Protagonist Therapeutics Inc's total assets grew from USD 10.3M in 2014 to USD 669.9M in 2025 (6386.2% over 11 years). Total assets compound annual growth rate: 5-year CAGR of 15.6%, 10-year CAGR of 46.4%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$8.96B
Implied Share Price
$138.43
Enterprise Value
$8.47B
Revenue (TTM)
$281.99M
EBITDA
$59.88M
Profit Margin
29.40%
Trailing P/E
134.40
Forward P/E
36.90
Price/Book (MRQ)
11.00
Price/Sales (TTM)
31.77
EV/EBITDA
141.64
EV/Revenue
30.08
Dividend Yield
—
Book Value
$13.01
Free Cash Flow (FY2025)
$56.08M
Free Cash Flow Yield
0.63%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.